Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Western Blot Products
  4. General Western Blot Reagents
  5. 502707866

Abcam D-Cycloserine, NMDA Glycine Site Agonist, 99% Purity, 5 g

Catalog No. 502707866
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 g
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-270-7866 5 g
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-270-7866 Supplier Abcam Supplier No. AB1201215G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Description

Partial agonist at the NMDA receptor glycine recognition site that enhances learning and memory in vivo.

  • Molecular weight: 102.09 Da
  • Purity: >99%
  • Chemical structure: (R)-4-amino-1,2-oxazolidin-3-one (100%)
  • Activity: Partial agonist at the NMDA receptor glycine recognition site
  • Biological effect: Enhances learning and memory in vivo; performance enhancer in cognitive models
  • CAS Number: 68-41-7

The product is subject to the following: Abcam Restricted Use Statement

Specifications

Shipping Condition Ambient
Target Molecule NMDA Receptor (Glycine Recognition Site)
Substrate Properties Chemical Substrate
Alternate Part Number ab146677
Buffer 100% (R)-4-amino-1,2-oxazolidin-3-one
Content And Storage Store at -20°C.
Form Powder
Formulation 100% (R)-4-amino-1,2-oxazolidin-3-one
Quantity 5 g
For Use With (Application) NMDA receptor agonist, learning and memory research, cognitive models
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.